Sort
82,697 grants matching “vaccine development”
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$2,761,944Alexander Pletnev · Niaid Extramural Activities · Z01 · FY2007 · AI
Defining signatures for immune responsiveness by functional systems immunology
$2,761,712David A. Hafler · Yale University · U19 · FY2013 · AI
Entry and replication of positive-sense, RNA viruses
$2,761,456Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
University of Pennsylvania HIV Clinical Trials Unit
$2,761,412Ian Frank · University Of Pennsylvania · UM1 · FY2025 · AI
Molecular and Immunologic Analysis of the Pathobiology of Anthrax
$2,760,181Oklahoma Medical Research Foundation · U19 · FY2004 · AI
Indiana University Melvin and Bren Simon Cancer Center Support Grant
$2,759,704Patrick J Loehrer · Indiana University Indianapolis · P30 · FY2019 · CA
Neurobiology of Addiction
$2,758,645George Koob · National Institute On Drug Abuse · ZIA · FY2023 · DA
Protective immunity following dengue virus natural infections and vaccination
$2,755,298Eva Harris · University Of California Berkeley · P01 · FY2017 · AI
Immunologic and virologic determinants of congenital Cytomegalovirus transmission and disease in rhesus monkeys
$2,755,195Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
Defining regulators of immunity to acute infection using CRISPR screens
$2,754,337Arlene H Sharpe · Harvard Medical School · U19 · FY2018 · AI
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
$2,753,572Vilasack Thammavongsa · Immunartes Llc · N01 · FY2024 · AI
Vaccine and Phylogeny Studies Of Simian Immunodeficiency Virus (SIV)
$2,752,905Vanessa M. Hirsch · Niaid Extramural Activities · Z01 · FY2007 · AI
Northern New England Clinical and Translational Research Network
$2,752,644Clifford J Rosen · Mainehealth · U54 · FY2023 · GM
Centralized HIV-1 Genes as Vaccines
$2,752,555Barton F Haynes · Duke University · P01 · FY2008 · AI
Operations and Management
$2,752,550Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2016 · AI
The Genome Analysis Core
$2,751,570Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI
Research Resources and Workforce Development for the Rocky Mountain Regional Biocontainment Laboratory at Colorado State University
$2,751,527Karen Marie Dobos · Colorado State University · UC7 · FY2023 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit
$2,751,253John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2020 · AI
Project 2: Development of vaccines in preclinical models to induce V2-apex bnAb responses
$2,750,363George M Shaw · University Of Pennsylvania · U19 · FY2025 · AI
IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine Effectiveness
$2,750,000Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2023 · IP
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases
$2,750,000Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2023 · IP
IP21-002 US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$2,749,997Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2023 · IP
Consolidated Basic Cancer Research Program
$2,749,311Dario C. Altieri · Wistar Institute · P30 · FY2019 · CA
Correlates of protection against SIV/SHIV challenge
$2,749,162Hildegund C. J. Ertl · Wistar Institute · P01 · FY2010 · AI
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses
$2,748,849Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2019 · AI